| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Braveheart Bio, Inc.
13G
BRVE · 10567X101
|
8.2% |
11/9/2026
Event 9/30/2026
|
||||
|
Kailera Therapeutics, Inc.
13G
KLRA · 482931102
|
8.9% |
8/5/2026
Event 6/30/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.